Moataz A. Shaldam

2.0k citations

75 papers · 1.5k indexed · h-index 24

Molecular Medicine top 5%
Organic Chemistry top 5%
- Synthesis and biological activity 23
- Synthesis and Catalytic Reactions 12
- Synthesis and Biological Evaluation 7
Toxicology top 5%
Endocrinology top 5%
Microbiology top 5%
Molecular Biology
- Bacterial biofilms and quorum sensing 17
- Enzyme function and inhibition 15
- Cancer therapeutics and mechanisms 7
Computational Theory and Mathematics
- Computational Drug Discovery Methods 8
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 6

Co-authors: Hisham A. Abbas Haytham O. Tawfik Wagdy M. Eldehna Claudiu T. Supuran Wael A. H. Hegazy El‐Sayed Khafagy Amira M. El-Ganiny Ahmed Elsherbini
Cited by: Molecular Medicine Organic Chemistry Toxicology
Journals: PLoS ONE (1 paper)Scientific Reports (2 papers)International Journal of Molecular Sciences (1 paper)
Partner nations: Egypt Saudi Arabia Italy

In The Last Decade

Moataz A. Shaldam

72 papers receiving 1.5k citations

Peers

Countries citing papers authored by Moataz A. Shaldam

Since Specialization

Citations

This map shows the geographic impact of Moataz A. Shaldam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moataz A. Shaldam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moataz A. Shaldam more than expected).

Fields of papers citing papers by Moataz A. Shaldam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moataz A. Shaldam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moataz A. Shaldam. The network helps show where Moataz A. Shaldam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Moataz A. Shaldam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Moataz A. Shaldam Line = papers co-authored together Moataz A. Shaldam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploring antitubercular activity of new coumarin derivatives targeting enoyl acyl carrier protein reductase (InhA): Synthesis, biological evaluation and computational studies Journal of Molecular Structure ·Manal S. Ebaid,Małgorzata Korycka‐Machała,Moataz A. Shaldam,Mohamed G. Thabit,Malwina Kawka,Bożena Dziadek,Magdalena Kuzioła,Hoda Atef Abdelsattar Ibrahim,Xinsheng Lei,Abdelsamed I. Elshamy,Jarosław Dziadek,Ahmed Sabt	2025	4
2	Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities Bioorganic Chemistry ·Heba A. Elsebaie,Tarek F. El‐Moselhy,Eman A. El-Bastawissy,Kamel M. Elberembally,Rehab Mustafa Badi,Eslam B. Elkaeed,Moataz A. Shaldam,Wagdy M. Eldehna,Haytham O. Tawfik	2024	21
3	New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling Bioorganic Chemistry ·Asmaa F. Kassem,Ahmed Sabt,Małgorzata Korycka‐Machała,Moataz A. Shaldam,Malwina Kawka,Bożena Dziadek,Magdalena Kuzioła,Jarosław Dziadek,Rasha Z. Batran	2024	6
4	A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments European Journal of Medicinal Chemistry ·Salma M. Hefny,Tarek F. El‐Moselhy,Nabaweya Sharaf El-Din,Andrea Ammara,Andrea Angeli,Marta Ferraroni,Ahmed M. El‐Dessouki,Moataz A. Shaldam,Galal Yahya,Ahmed A. Al‐Karmalawy,Claudiu T. Supuran,Haytham O. Tawfik	2024	30
5	Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments Bioorganic Chemistry ·Heba A. Elsebaie,Maha‐Hamadien Abdulla,Zainab M. Elsayed,Moataz A. Shaldam,Haytham O. Tawfik,Samar N Morsy,Mansoor-Ali Vaali Mohammed,Thamer Bin Traiki,Eslam B. Elkaeed,Hatem A. Abdel‐Aziz,Wagdy M. Eldehna	2024	16
6	Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations Journal of Molecular Structure ·Moataz A. Shaldam,Maha‐Hamadien Abdulla,Andrea Angeli,Salma M. Hefny,Eman M. El‐labbad,Abdullah Bin Obeed,Noura Alhassan,Claudiu T. Supuran,Wagdy M. Eldehna,Haytham O. Tawfik	2024	11
7	Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors Bioorganic Chemistry ·Ahmed Sabt,Eman F. Khaleel,Moataz A. Shaldam,Manal S. Ebaid,Rehab Mustafa Badi,Abdou Kamal Allayeh,Wagdy M. Eldehna,Jarosław Dziadek	2024	12
8	Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity RSC Advances ·Tarfah Al‐Warhi,Ahmed Sabt,Małgorzata Korycka‐Machała,Asmaa F. Kassem,Moataz A. Shaldam,Hoda Atef Abdelsattar Ibrahim,Malwina Kawka,Bożena Dziadek,Magdalena Kuzioła,Wagdy M. Eldehna,Jarosław Dziadek	2024	5
9	2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling European Journal of Medicinal Chemistry ·Moataz A. Shaldam,Denisa Hendrychová,Radwan El‐Haggar,Veronika Vojáčková,Taghreed A. Majrashi,Eslam B. Elkaeed,Nicolas Masurier,Vladimı́r Kryštof,Haytham O. Tawfik,Wagdy M. Eldehna	2023	19
10	Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights Bioorganic Chemistry ·Heba A. Elsebaie,Eman A. El-Bastawissy,Kamel M. Elberembally,Eman F. Khaleel,Rehab Mustafa Badi,Moataz A. Shaldam,Wagdy M. Eldehna,Haytham O. Tawfik,Tarek F. El‐Moselhy	2023	30
11	Metolazone co-crystals-loaded oral fast dissolving films: Design, optimization, and in vivo evaluation Journal of Drug Delivery Science and Technology ·Mohamed S. Mohamed,Ahmed A. El-Shenawy,H. E. Ramadan,Essam A. Mahmoud,M. Amin,Hamdoon A. Mohammed,Moataz A. Shaldam,Reda A. Mahmoud	2023	3
12	1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities Journal of Medicinal Chemistry ·Ahmed E. Elsawi,Mostafa M. Elbadawi,Alessio Nocentini,Hadia Almahli,Simone Giovannuzzi,Moataz A. Shaldam,Rofaida Salem,Tamer M. Ibrahim,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Wagdy M. Eldehna	2023	49
13	Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa Microorganisms ·Maan T. Khayat,Tarek S. Ibrahim,Ahdab N. Khayyat,Majed Alharbi,Moataz A. Shaldam,Khadijah A. Mohammad,El‐Sayed Khafagy,Dalia A. El-damasy,Wael A. H. Hegazy,Hisham A. Abbas	2022	38
14	Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity Journal of Enzyme Inhibition and Medicinal Chemistry ·Haytham O. Tawfik,Moataz A. Shaldam,Alessio Nocentini,Rofaida Salem,Hadia Almahli,Sara T. Al‐Rashood,Claudiu T. Supuran,Wagdy M. Eldehna	2022	28
15	In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes Environmental Science and Pollution Research ·Moataz A. Shaldam,Galal Yahya,Nashwa H. Mohamed,Mohamed M. Abdel‐Daim,Yahya Al Naggar	2021	56
16	Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors International Journal of Molecular Sciences ·Moataz A. Shaldam,Alessio Nocentini,Zainab M. Elsayed,Tamer M. Ibrahim,Rofaida Salem,Ramadan A. El-Domany,Clemente Capasso,Claudiu T. Supuran,Wagdy M. Eldehna	2021	27
17	Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens Microorganisms ·Ahdab N. Khayyat,Wael A. H. Hegazy,Moataz A. Shaldam,Rasha Mosbah,Ahmad J. Almalki,Tarek S. Ibrahim,Maan T. Khayat,El‐Sayed Khafagy,Wafaa E. Soliman,Hisham A. Abbas	2021	41
18	Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon Antibiotics ·Mohammed F. Aldawsari,El‐Sayed Khafagy,Ahmed Al Saqr,Ahmed Alalaiwe,Hisham A. Abbas,Moataz A. Shaldam,Wael A. H. Hegazy,Reham M. Goda	2021	51
19	Multi-Spectroscopic, thermodynamic and molecular dynamic simulation studies for investigation of interaction of dapagliflozin with bovine serum albumin Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Mohamed A. Abdelaziz,Moataz A. Shaldam,Ramadan A. El-Domany,Fathalla Belal	2021	57
20	A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in Pseudomonas aeruginosa Antibiotics ·Ahmed Al Saqr,Mohammed F. Aldawsari,El‐Sayed Khafagy,Moataz A. Shaldam,Wael A. H. Hegazy,Hisham A. Abbas	2021	49

About Moataz A. Shaldam

Moataz A. Shaldam is a scholar working on Organic Chemistry, Molecular Medicine and Molecular Biology, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (23 papers), Bacterial biofilms and quorum sensing (17 papers), Enzyme function and inhibition (15 papers), Synthesis and Catalytic Reactions (12 papers), Computational Drug Discovery Methods (8 papers), Cancer therapeutics and mechanisms (7 papers), Synthesis and Biological Evaluation (7 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Molecular Medicine (160 citations), Organic Chemistry (564 citations) and Toxicology (61 citations). Moataz A. Shaldam has collaborated with scholars based in Egypt, Saudi Arabia and Italy. Frequent co-authors include Hisham A. Abbas, Haytham O. Tawfik, Wagdy M. Eldehna, Claudiu T. Supuran, Wael A. H. Hegazy, El‐Sayed Khafagy, Amira M. El-Ganiny, Ahmed Elsherbini, Rofaida Salem and Ramadan A. El-Domany. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact